Fecha de publicación: -- Fuente: Biotechblog Lugar: General Biotechnology CRISPR was supposed to be protected by platform patents. Fourteen years later, the litigation story says: not really.
For years, the gene-editing industry has operated on a kind of legal common sense: broad, platform patents would establish stable grou...
Source